Gastroenterology
Volume 138, Issue 1 , Pages 82-88 , January 2010

Famotidine Is Inferior to Pantoprazole in Preventing Recurrence of Aspirin-Related Peptic Ulcers or Erosions

  • Fook–Hong Ng

      Affiliations

    • Department of Medicine and Geriatric, Ruttonjee Hospital, Hong Kong, China
    • Corresponding Author InformationReprint requests Address requests for reprints to: Fook-Hong Ng, MD, Department of Medicine, Ruttonjee Hospital, 266 Queen's Road East, Wai Chai, Hong Kong, China
    • ,
  • Siu–Yin Wong

      Affiliations

    • Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
    • ,
  • Kwok–Fai Lam

      Affiliations

    • Department of Statistics and Actuarial Science, University of Hong Kong, Hong Kong, China
    • ,
  • Wai–Ming Chu

      Affiliations

    • Department of Medicine and Geriatric, Ruttonjee Hospital, Hong Kong, China
    • ,
  • Pierre Chan

      Affiliations

    • Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China
    • ,
  • Yuk–Hei Ling

      Affiliations

    • Department of Surgery, Ruttonjee Hospital, Hong Kong, China
    • ,
  • Carolyn Kng

      Affiliations

    • Department of Medicine and Geriatric, Ruttonjee Hospital, Hong Kong, China
    • ,
  • Wai–Cheung Yuen

      Affiliations

    • Department of Surgery, Ruttonjee Hospital, Hong Kong, China
    • ,
  • Yuk–Kong Lau

      Affiliations

    • Department of Medicine and Geriatric, Ruttonjee Hospital, Hong Kong, China
    • ,
  • Ambrose Kwan

      Affiliations

    • Department of Pharmacy, Ruttonjee Hospital, Hong Kong, China
    • ,
  • Benjamin C.Y. Wong

      Affiliations

    • Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong, China

Received 23 June 2009 ,Accepted 30 September 2009.

References 

  1. Collaborative overview of randomised trials of antiplatelet therapy I. prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81–106
  2. UK-TIA Study Group. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54:1044–1054
  3. Chan FKL, Chung SC, Yuen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med. 2001;344:967–973
  4. Lai KC, Lam SK, Chu KM, et al. Lansprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med. 2002;346:2033–2038
  5. Ng FH, Wong SY, Chang CM, et al. High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther. 2003;18:443–449
  6. Chan FKL, Ching JYL, Hung LCT, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352:238–244
  7. Lai KC, Chu KM, Hui WM, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol. 2006;4:860–865
  8. Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol. 2008;103:2890–2907
  9. Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs. N Engl J Med. 1996;334:1435–1439
  10. Hudson N, Haha AS, Russell RI, et al. Famotidine for healing and maintenance in nonsteroidal anti-inflammatory drug-associated gastroduodenal ulceration. Gastroenterology. 1997;112:1817–1822
  11. Rostom A, Dube C, Wells G, et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev. 2002;4:CD002296
  12. Yin Q, Chow SS, Tomlinson B. Clinical bioequivalence study on two famotidine formulations (Famolta vs Pepcidine). Hong Kong: The Chinese University of Hong Kong; March 15, 2003;
  13. Yeomans ND, Tulassay Z, Juhász L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med. 1998;338:719–726
  14. Lwanga SK, Lemeshow S. Sample size determination in health studies. Geneva, Switzerland: World Health Organization; 1991;
  15. Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial—phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol. 1988;11:1–11
  16. Lanas A, Bajador E, Serrano P, et al. Nitrovasodilators, low-dose aspirin, other nonsteroidal anti-inflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med. 2000;343:834–839
  17. Lanas A, García Rodríguez LA, Arroyo MT, et al. Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol. 2007;102:507–515
  18. Taha AS, McCloskey C, Prasad R, et al. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:119–125
  19. Laheij RJ, Van Rossum LG, Jansen JB, et al. Proton-pump inhibitor therapy for acetylsalicylic acid associated upper gastrointestinal symptoms: a randomized placebo-controlled trial. Aliment Pharmacol Ther. 2003;18:109–115
  20. Yeomans N, Lanas A, Labenz J, et al. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin. Am J Gastroenterol. 2008;103:2465–2473
  21. Laheij RJ, van Rossum LG, Jansen JB, et al. Quality of life implications in patients with cardiovascular disease and dyspeptic symptoms. Gastroenterology. 2002;122(Suppl 1):785
  22. Pounder R. Silent peptic ulceration: deadly silence or golden silence?. Gastroenterology. 1989;96:626–631
  23. Hilton D, Iman N, Burke GJ, et al. Absence of abdominal pain in older persons with endoscopic ulcers: a prospective study. Am J Gastroenterol. 2001;96:380–384
  24. Famotidine: drug information. Up To Date website http://www.uptodate.com/online/content/topic.do?topicKey=drug_a_K/102624Accessed June 1, 2008
  25. Hui WM, Lam SK, Ho J, et al. Effect of sucralfate and cimetidine on duodenal ulcer-associated antral gastritis and Campylobacter pylori. Am J Med. 1989;86:60–65
  26. Cappell MS. The safety and clinical utility of esophagogastroduodenoscopy for acute gastrointestinal bleeding after myocardial infarction: a six-year study of 42 endoscopies in 34 consecutive patients at two university teaching hospitals. Am J Gastroenterol. 1993;88:344–350

 Conflicts of interest The authors disclose no conflicts.

 Funding Sponsored by the Ruttonjee Hospital for the administration and expenditure for drug and repacking of tablets.

PII: S0016-5085(09)01762-4

doi: 10.1053/j.gastro.2009.09.063

Gastroenterology
Volume 138, Issue 1 , Pages 82-88 , January 2010

Article Tools